While some mutations in the BRCA2 gene clearly indicate risks for breast and prostate cancer, thousands of less-common variations have confounded doctors and left anxious patients without guidance ...
Testing for BRCA mutations linked to breast and ovarian cancers could become easier and more accessible with the help of artificial intelligence, potentially allowing earlier treatment.
In a groundbreaking shift in our understanding of mutations, researchers have discovered types of DNA damage in healthy cells that can remain unrepaired for years. While most types of DNA damage are ...
Germline mutations in BRCA1 and BRCA2 and a few other rare variants account for only 15–20% of breast cancer that clusters in families and less than 5% of breast cancer overall. So what are we ...
Researchers at the Wellcome Sanger Institute have uncovered a surprising form of DNA damage that persists for years without repair, posing risks for generating harmful mutations. The findings shed ...
Jan. 24, 2025 — A new study shows that long-read sequencing has the potential to improve the rate of diagnosis while reducing the time to diagnosis from years to days -- in a single test and at ...